AssetMark’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
AssetMark's RYTM Position: Q3 2026 in Review
AssetMark opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 3 shares worth $286. The stake represents ﹤0.01% of the portfolio and ranks #3551 among its holdings.
239 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- AssetMark held 3 shares of Rhythm Pharmaceuticals worth $286 as of Q3 2026.
- Rhythm Pharmaceuticals was a new AssetMark position in Q3 2026.
- Rhythm Pharmaceuticals made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3551 holding.
- 239 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.